Low-dose il-2 reduces il-21+ t cell frequency and induces anti-inflammatory gene expression in type 1 diabetes

HIGHLIGHTS

• who: Jia-Yuan Zhang from the (UNIVERSITY) have published the paper: Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes, in the Journal: (JOURNAL) of 10/04/2022
• what: The authors examine the effects of interval administration of low-dose recombinant IL-2 (iLD-IL-2) in type 1 diabetes using high-resolution single-cell multiomics and flow cytometry on longitudinally-collected peripheral blood samples. Although the authors show that iLD-IL-2 can induce this signature, it is certainly not the only responsible . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.